1. Home
  2. CYTH vs FKWL Comparison

CYTH vs FKWL Comparison

Compare CYTH & FKWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • FKWL
  • Stock Information
  • Founded
  • CYTH 1990
  • FKWL 1981
  • Country
  • CYTH United States
  • FKWL United States
  • Employees
  • CYTH N/A
  • FKWL N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • FKWL Telecommunications Equipment
  • Sector
  • CYTH Health Care
  • FKWL Utilities
  • Exchange
  • CYTH Nasdaq
  • FKWL Nasdaq
  • Market Cap
  • CYTH 35.5M
  • FKWL 35.5M
  • IPO Year
  • CYTH N/A
  • FKWL 1996
  • Fundamental
  • Price
  • CYTH $1.12
  • FKWL $4.15
  • Analyst Decision
  • CYTH Strong Buy
  • FKWL
  • Analyst Count
  • CYTH 3
  • FKWL 0
  • Target Price
  • CYTH $3.20
  • FKWL N/A
  • AVG Volume (30 Days)
  • CYTH 41.8K
  • FKWL 21.6K
  • Earning Date
  • CYTH 08-12-2024
  • FKWL 07-30-2024
  • Dividend Yield
  • CYTH N/A
  • FKWL N/A
  • EPS Growth
  • CYTH N/A
  • FKWL N/A
  • EPS
  • CYTH N/A
  • FKWL N/A
  • Revenue
  • CYTH $1,126,444.00
  • FKWL $41,683,786.00
  • Revenue This Year
  • CYTH $28.30
  • FKWL N/A
  • Revenue Next Year
  • CYTH $14.19
  • FKWL N/A
  • P/E Ratio
  • CYTH N/A
  • FKWL N/A
  • Revenue Growth
  • CYTH N/A
  • FKWL 1.45
  • 52 Week Low
  • CYTH $0.89
  • FKWL $2.69
  • 52 Week High
  • CYTH $2.12
  • FKWL $4.26
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 38.04
  • FKWL 77.40
  • Support Level
  • CYTH $1.12
  • FKWL $4.02
  • Resistance Level
  • CYTH $1.20
  • FKWL $4.26
  • Average True Range (ATR)
  • CYTH 0.09
  • FKWL 0.12
  • MACD
  • CYTH -0.01
  • FKWL 0.03
  • Stochastic Oscillator
  • CYTH 0.00
  • FKWL 86.42

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

Share on Social Networks: